AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15301650 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) in individual face-to-face therapy
Number of subjects: 45
Study 15301650 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) through brief individual telephone consultations
Number of subjects: 45
Study 15301650 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 45
Study 11142580 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% glyceryl trinitrate ointment (PMF 303)
Number of subjects: 12
Study 11142580 — intervention group
Group type: COMPARATOR
Intervention: Common preparation of glyceryl trinitrate ointment
Number of subjects: 12
Study 9487449 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-sitosterol
Number of subjects: 37
Study 9487449 — intervention group
Group type: COMPARATOR
Intervention: Placebo (talcum powder)
Number of subjects: 37
Study 8404405 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-ASA colonic foam
Number of subjects: 233
Study 8404405 — intervention group
Group type: COMPARATOR
Intervention: 5-ASA enema
Number of subjects: 233
Study 3526866 — intervention group
Group type: EXPERIMENTAL
Intervention: Acellular pertussis vaccine
Number of subjects: 80
Study 3526866 — intervention group
Group type: COMPARATOR
Intervention: Conventional pertussis vaccine
Number of subjects: 80
Study 29754669 — intervention group
Group type: EXPERIMENTAL
Intervention: FFR-guided PCI strategy
Number of subjects: 1700
Study 29754669 — intervention group
Group type: COMPARATOR
Intervention: IVUS-guided PCI strategy
Number of subjects: 1700
Study 27296723 — intervention group
Group type: EXPERIMENTAL
Intervention: Play & Grow intervention (weekly one-hour activity sessions for 10 weeks)
Number of subjects: 240
Study 27296723 — intervention group
Group type: EXPERIMENTAL
Intervention: Connectedness to nature (part of the Play & Grow intervention)
Number of subjects: 240
Study 27296723 — intervention group
Group type: EXPERIMENTAL
Intervention: Nature Relatedness Scale (NRS)
Number of subjects: 240
Study 24561645 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-based intervention teaching SNAPPI
Number of subjects: 0
Study 23880545 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabeprazole 20 mg
Number of subjects: 0
Study 23880545 — intervention group
Group type: COMPARATOR
Intervention: Pantoprazole 40 mg
Number of subjects: 0
Study 20100629 — intervention group
Group type: EXPERIMENTAL
Intervention: Online assessment tool
Number of subjects: 50
Study 20100629 — intervention group
Group type: COMPARATOR
Intervention: Practical assessment tool (OSCE style)
Number of subjects: 50
Study 18324427 — intervention group
Group type: EXPERIMENTAL
Intervention: Caspofungin therapy for invasive candidiasis (IC)
Number of subjects: 159
Study 18324427 — intervention group
Group type: EXPERIMENTAL
Intervention: Caspofungin therapy for invasive aspergillosis (IA)
Number of subjects: 159
Study 18324427 — intervention group
Group type: EXPERIMENTAL
Intervention: Caspofungin therapy as empirical therapy (ET)
Number of subjects: 159
Study 18324427 — intervention group
Group type: EXPERIMENTAL
Intervention: Caspofungin therapy
Number of subjects: 159
Study 16193475 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based health centers (SBHCs) intervention
Number of subjects: 0
Study 16193475 — intervention group
Group type: COMPARATOR
Intervention: Control schools (no SBHCs)
Number of subjects: 0
Study 16193475 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (intervention and control)
Number of subjects: 0
Study 12382303 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group
Number of subjects: 0
Study 12382303 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 10790574 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser photocoagulation
Number of subjects: 0
Study 10790574 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 7755939 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine (5 to 20 mg; n = 13)
Number of subjects: 28
Study 7755939 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril (2.5 to 10 mg; n = 15)
Number of subjects: 28
Study 7755939 — intervention group
Group type: COMPARATOR
Intervention: Control group (normotensive men)
Number of subjects: 28
Study 2274600 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (20-80 mg bid)
Number of subjects: 47
Study 2274600 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (0.1-0.3 mg bid)
Number of subjects: 47
Study 2274600 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (20-40 mg bid)
Number of subjects: 47
Study 2274600 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 7027073 — intervention group
Group type: EXPERIMENTAL
Intervention: Bobath
Number of subjects: 30
Study 7027073 — intervention group
Group type: EXPERIMENTAL
Intervention: Vojta
Number of subjects: 30
Study 7027073 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 30
Study 30924254 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-in-1 night facial serum (NFS) containing melatonin, bakuchiol, and ascorbyl tetraisopalmitate, applied once daily for 12 weeks
Number of subjects: 103
Study 30924254 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-in-1 night facial serum (NFS)
Number of subjects: 103
Study 30954276 — intervention group
Group type: COMPARATOR
Intervention: Incremental Cycle Test (ICT)
Number of subjects: 40
Study 30954276 — intervention group
Group type: EXPERIMENTAL
Intervention: ISWT and 6MWT
Number of subjects: 40
Study 29162117 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based intervention including advocacy meetings, training community representatives for peer education, and integrating awareness creation with community health extension program.
Number of subjects: 1269
Study 29162117 — intervention group
Group type: COMPARATOR
Intervention: Active comparator group without husband involvement in the intervention.
Number of subjects: 1269
Study 26158441 — intervention group
Group type: EXPERIMENTAL
Intervention: Endobronchial ultrasound-guided transbronchial needle aspiration with rapid on-site evaluation (ROSE)
Number of subjects: 126
Study 26158441 — intervention group
Group type: COMPARATOR
Intervention: Endobronchial ultrasound-guided transbronchial needle aspiration without rapid on-site evaluation (EBUS)
Number of subjects: 126
Study 24501946 — intervention group
Group type: EXPERIMENTAL
Intervention: Itopride (IG) 50 mg 3 times a day (tid)
Number of subjects: 90
Study 24501946 — intervention group
Group type: COMPARATOR
Intervention: Domperidone (DP) 10 mg tid
Number of subjects: 90
Study 24501946 — intervention group
Group type: EXPERIMENTAL
Intervention: Itopride (IG)
Number of subjects: 90
Study 24501946 — intervention group
Group type: COMPARATOR
Intervention: Domperidone (DP)
Number of subjects: 90
Study 21626121 — intervention group
Group type: EXPERIMENTAL
Intervention: Betahistine dihydrochloride 288-480 mg/day
Number of subjects: 11
Study 17530429 — intervention group
Group type: EXPERIMENTAL
Intervention: CMF (cyclophosphamide, methotrexate, 5‐fluorouracil)
Number of subjects: 281
Study 17123186 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Cranial Electrotherapy Stimulation (CES)
Number of subjects: 38
Study 17123186 — intervention group
Group type: COMPARATOR
Intervention: Sham Cranial Electrotherapy Stimulation (CES)
Number of subjects: 38
Study 12642755 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual therapy
Number of subjects: 49
Study 12642755 — intervention group
Group type: COMPARATOR
Intervention: Exercise therapy
Number of subjects: 49
Study 10842890 — intervention group
Group type: COMPARATOR
Intervention: Randomized clinical trial design measuring drug activity on acute parameters.
Number of subjects: 102
Study 10842890 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of efficacy in clinical practice.
Number of subjects: 102
Study 10842890 — intervention group
Group type: EXPERIMENTAL
Intervention: Observational studies as an alternative to randomized trials.
Number of subjects: 102
Study 10842890 — intervention group
Group type: EXPERIMENTAL
Intervention: Parameters considered fundamental by the patient (chronic pain, disability, radiographic alterations).
Number of subjects: 102
Study 9314427 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine (2.5 to 10 mg BID) on high-salt diet
Number of subjects: 21
Study 9314427 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine (2.5 to 10 mg BID) on low-salt diet
Number of subjects: 21
Study 8363080 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous platelet-rich plasma
Number of subjects: 56
Study 8363080 — intervention group
Group type: COMPARATOR
Intervention: Sham product
Number of subjects: 56
Study 3524465 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunochemotherapy (L-I-C)
Number of subjects: 234
Study 3524465 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-operative chemotherapy (L-I-C)
Number of subjects: 234
Study 3524465 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term continuous chemotherapy (L-C-C)
Number of subjects: 234
Study 3524465 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term continuous chemotherapy (L-C-C) with CQ+CPA+ADM+5-FU
Number of subjects: 234
Study 3524465 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-operative radiation therapy
Number of subjects: 234
Study 3524465 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunotherapy combined with radiation therapy
Number of subjects: 234
Study 3524465 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchial arterial infusion (BAI)
Number of subjects: 234
Study 3524465 — intervention group
Group type: COMPARATOR
Intervention: Short-term chemotherapy (S-C)
Number of subjects: 234
Study 3524465 — intervention group
Group type: COMPARATOR
Intervention: Long-term intermittent chemotherapy (L-I-C)
Number of subjects: 234
Study 3524465 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (control group)
Number of subjects: 234
Study 29792037 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone‐iodine pleurodesis
Number of subjects: 60
Study 29792037 — intervention group
Group type: COMPARATOR
Intervention: Bleomycin pleurodesis
Number of subjects: 60
Study 27734748 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetuximab with radiotherapy (ERT)
Number of subjects: 20
Study 27734748 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin with radiotherapy (CRT)
Number of subjects: 20
Study 23999209 — intervention group
Group type: EXPERIMENTAL
Intervention: Custom cutting blocks
Number of subjects: 80
Study 23999209 — intervention group
Group type: COMPARATOR
Intervention: Conventional TKA instrumentation
Number of subjects: 80
Study 22059447 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of category labels during similarity judgments
Number of subjects: 0
Study 22059447 — intervention group
Group type: COMPARATOR
Intervention: Absence of category labels during similarity judgments
Number of subjects: 0
Study 20675691 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline serum fibrosis markers (HA, YKL-40, TIMP-1)
Number of subjects: 462
Study 20675691 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline HA and platelet counts
Number of subjects: 462
Study 18774627 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital meals
Number of subjects: 60
Study 15761945 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol dry powder inhalers with fine particle doses (FPDs) of 100 microg
Number of subjects: 12
Study 15761945 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol dry powder inhalers with fine particle doses (FPDs) of 120 microg
Number of subjects: 12
Study 15761945 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol dry powder inhalers with fine particle doses (FPDs) of 160 microg
Number of subjects: 12
Study 15761945 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol dry powder inhalers
Number of subjects: 12
Study 12649515 — intervention group
Group type: EXPERIMENTAL
Intervention: Triflusal (600 mg/d)
Number of subjects: 2113
Study 12649515 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (325 mg/d)
Number of subjects: 2113
Study 12649515 — intervention group
Group type: EXPERIMENTAL
Intervention: Triflusal
Number of subjects: 2113
Study 12649515 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 2113
Study 10357343 — intervention group
Group type: COMPARATOR
Intervention: Granisetron 3 mg
Number of subjects: 120
Study 10357343 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron 3 mg plus dexamethasone 8 mg
Number of subjects: 120
Study 8730935 — intervention group
Group type: EXPERIMENTAL
Intervention: SSRIs
Number of subjects: 0
Study 8730935 — intervention group
Group type: COMPARATOR
Intervention: TCAs
Number of subjects: 0
Study 2802477 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic dilatation and antireflux medication
Number of subjects: 195
Study 2802477 — intervention group
Group type: COMPARATOR
Intervention: Antireflux surgery
Number of subjects: 195
Study 990784 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone 40 mug administered intravenously one minute after birth
Number of subjects: 44
Study 990784 — intervention group
Group type: COMPARATOR
Intervention: Control group (epidural block)
Number of subjects: 44
Study 990784 — intervention group
Group type: COMPARATOR
Intervention: Untreated neonates of mothers who had pethidine
Number of subjects: 44
Study 31185078 — intervention group
Group type: EXPERIMENTAL
Intervention: Scabies prevalence in the population examined
Number of subjects: 1879
Study 29163985 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled loxapine 5 or 10 mg
Number of subjects: 658
Study 29163985 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 658
Study 26288391 — intervention group
Group type: EXPERIMENTAL
Intervention: Trail Making Test A and B (TM A and B) at enrollment and at 12 and 24 months
Number of subjects: 2128
Study 26288391 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in TM B times
Number of subjects: 2128
Study 26288391 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in TM scores
Number of subjects: 2128
Study 26288391 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung function, PaO2, smoking status
Number of subjects: 2128
Study 23456209 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedentary time
Number of subjects: 878
Study 23456209 — intervention group
Group type: EXPERIMENTAL
Intervention: Breaks in sedentary time
Number of subjects: 878
Study 23456209 — intervention group
Group type: EXPERIMENTAL
Intervention: Total physical activity
Number of subjects: 878
Study 23456209 — intervention group
Group type: EXPERIMENTAL
Intervention: MVPA
Number of subjects: 878
Study 22187590 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling by community volunteers in the intervention group
Number of subjects: 179
Study 22187590 — intervention group
Group type: COMPARATOR
Intervention: Control group (no counseling)
Number of subjects: 179
Study 19929234 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth group using the Health Buddy system for an additional 180 days
Number of subjects: 0
Study 19929234 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving no further telehealth or home health services
Number of subjects: 0
Study 19929234 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth group
Number of subjects: 0
Study 22369559 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass-ionomer cements (GICs) and resin-modified glass-ionomer cements (RMGICs) incorporated with 2% chlorhexidine (CHX)
Number of subjects: 0
Study 22369559 — intervention group
Group type: COMPARATOR
Intervention: Control group: Conventional glass-ionomer cements (GIC) and resin-modified glass-ionomer cements (RMGIC) without chlorhexidine
Number of subjects: 0
Study 16519083 — intervention group
Group type: EXPERIMENTAL
Intervention: Early postpartum mother-baby skin-to-skin contact
Number of subjects: 92
Study 16519083 — intervention group
Group type: EXPERIMENTAL
Intervention: Early initiation of breastfeeding
Number of subjects: 92
Study 16519083 — intervention group
Group type: COMPARATOR
Intervention: Mode of delivery (vaginal or caesarian)
Number of subjects: 92
Study 12006271 — intervention group
Group type: EXPERIMENTAL
Intervention: n‐BCA/Tantalum Powder/Ethiodized Oil mixture
Number of subjects: 104
Study 12006271 — intervention group
Group type: COMPARATOR
Intervention: Trufill polyvinyl alcohol (PVA)
Number of subjects: 104
Study 12006271 — intervention group
Group type: EXPERIMENTAL
Intervention: n‐BCA
Number of subjects: 104
Study 12006271 — intervention group
Group type: COMPARATOR
Intervention: PVA
Number of subjects: 104
Study 9834807 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevel parallel to the longitudinal axis of the dural cylinder
Number of subjects: 212
Study 9834807 — intervention group
Group type: COMPARATOR
Intervention: Bevel transverse to the longitudinal axis of the dural cylinder
Number of subjects: 212
Study 8083144 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with ADHD
Number of subjects: 23
Study 8083144 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 23
Study 2916917 — intervention group
Group type: EXPERIMENTAL
Intervention: Viscoelastic insoles
Number of subjects: 139
Study 2916917 — intervention group
Group type: COMPARATOR
Intervention: Placebo foam insoles
Number of subjects: 139
Study 939844 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived own control over noise condition
Number of subjects: 40
Study 939844 — intervention group
Group type: COMPARATOR
Intervention: No control over noise condition
Number of subjects: 40
Study 939844 — intervention group
Group type: EXPERIMENTAL
Intervention: Constant rate of exposure to noise
Number of subjects: 40
Study 939844 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing rate of exposure to noise
Number of subjects: 40
Study 31991617 — intervention group
Group type: EXPERIMENTAL
Intervention: Better education
Number of subjects: 523
Study 31991617 — intervention group
Group type: EXPERIMENTAL
Intervention: Shift work
Number of subjects: 523
Study 31991617 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurses in management positions
Number of subjects: 523
Study 31991617 — intervention group
Group type: EXPERIMENTAL
Intervention: Scale of well-being
Number of subjects: 523
Study 30093595 — intervention group
Group type: EXPERIMENTAL
Intervention: Notification of patients' deaths and a safe prescribing injunction from the county's medical examiner
Number of subjects: 861
Study 30093595 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 861
Study 29474712 — intervention group
Group type: EXPERIMENTAL
Intervention: Average on-treatment SBP ≤130 mmHg
Number of subjects: 8778
Study 29474712 — intervention group
Group type: COMPARATOR
Intervention: Average on-treatment SBP between 131 and 141 mmHg
Number of subjects: 8778
Study 29474712 — intervention group
Group type: COMPARATOR
Intervention: Average on-treatment SBP ≥142 mmHg
Number of subjects: 8778
Study 24229565 — intervention group
Group type: EXPERIMENTAL
Intervention: Entacapone
Number of subjects: 0
Study 24229565 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 23328286 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 ml/d lactulose
Number of subjects: 112
Study 23328286 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 ml/d lactulose
Number of subjects: 112
Study 23328286 — intervention group
Group type: EXPERIMENTAL
Intervention: 90 ml/d lactulose
Number of subjects: 112
Study 20131262 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2439821 (0.2 mg/kg)
Number of subjects: 97
Study 20131262 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2439821 (2.0 mg/kg)
Number of subjects: 97
Study 20131262 — intervention group
Group type: EXPERIMENTAL
Intervention: All LY2439821 combined
Number of subjects: 97
Study 20131262 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study 20131262 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2439821 (0.2, 0.6, or 2.0 mg/kg)
Number of subjects: 97
Study 20131262 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2439821
Number of subjects: 97
Study 18467621 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital photoplethysmography (D‐PPG) test in patients with high PAP
Number of subjects: 90
Study 18467621 — intervention group
Group type: COMPARATOR
Intervention: Digital photoplethysmography (D‐PPG) test in patients without high PAP
Number of subjects: 90
Study 18467621 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between venous refilling time (RT) and D‐PPG results in patients with high PAP
Number of subjects: 90
Study 18467621 — intervention group
Group type: COMPARATOR
Intervention: Correlation between venous refilling time (RT) and D‐PPG results in patients without high PAP
Number of subjects: 90
Study 15808630 — intervention group
Group type: EXPERIMENTAL
Intervention: Celsior (CEL)
Number of subjects: 40
Study 15808630 — intervention group
Group type: COMPARATOR
Intervention: Histidine Tryptophan Ketoglutarate (HTK)
Number of subjects: 40
Study 12027796 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial artery grafts (RA), n=154 patients
Number of subjects: 289
Study 12027796 — intervention group
Group type: COMPARATOR
Intervention: Saphenous vein grafts (SVG), n=135 patients
Number of subjects: 289
Study 12198775 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 8746882 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg estradiol-valerat (E2V) and 10 mg dydrogesterone for 10 months
Number of subjects: 23
Study 8746882 — intervention group
Group type: COMPARATOR
Intervention: No hormonal treatment
Number of subjects: 23
Study 2143712 — intervention group
Group type: EXPERIMENTAL
Intervention: d‐fenfluramine (30 mg daily)
Number of subjects: 42
Study 2143712 — intervention group
Group type: COMPARATOR
Intervention: placebo plus low‐calorie diet (1500‐1200 kcal daily)
Number of subjects: 42
Study 7391826 — intervention group
Group type: EXPERIMENTAL
Intervention: Condition designed to elicit spontaneous fantasy behavior
Number of subjects: 57
Study 7391826 — intervention group
Group type: COMPARATOR
Intervention: Control condition designed to be incompatible with fantasy
Number of subjects: 57
Study 31983177 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronomic chemotherapy
Number of subjects: 81
Study 31983177 — intervention group
Group type: COMPARATOR
Intervention: Palliative hydroxyurea
Number of subjects: 81
Study 31076620 — intervention group
Group type: EXPERIMENTAL
Intervention: CNN-based system for predicting patient sex from FDG PET-CT images
Number of subjects: 6462
Study 31076620 — intervention group
Group type: EXPERIMENTAL
Intervention: Image-masking simulation
Number of subjects: 6462